bioactive pth was raised above normal ( normal range : undetectable to 4.6 pmol human pth ( 1-34 ) per 1 ) in 13/17 ( 76 % ) patients with primary hyperparathyroidism , in 5/6 ( 83 % ) patients with surgically proven hyperparathyroidism secondary to chronic renal failure , in 4/5 ( 80 % ) patients with hyperparathyroidism secondary to hypocalcaemia , in all three patients with pseudohypoparathyroidism , in 5/17 ( 29 % ) patients with osteoporosis and in 1/9 ( 11 % ) patients with renal stones and/or hypercalciuria .
C0221002
primary hyperparathyroidism
C0020502
hyperparathyroidism